SA Tuberculosis Vaccine Initiative

Search

June 2016

30 June 2016 SATVI Labs approved by IQA Cryopreservation Proficiency Testing Advisory Group (ICAG) - 30 Jun 2016 - 12:45
30 June 2016 SATVI Labs approved by IQA Cryopreservation Proficiency Testing Advisory Group (ICAG) - 30 Jun 2016 - 12:45
20 June 2016 SATVI acquires robot to assist with RNA extractions - 20 Jun 2016 - 21:45
13 June 2016 Postdoctoral Fellow in Systems Immunology - 13 Jun 2016 - 15:30
10 June 2016 SATVI Labs approved by ACTG - 10 Jun 2016 - 12:45

May 2016

20 May 2016 Vacancies Clinical Research Workers - 20 May 2016 - 08:00
18 May 2016 Biomarker study provides insight into TB disease risk in young children - 18 May 2016 - 21:30
17 May 2016 Cape Winelands TB Awareness Program launched in Robertson - 18 May 2016 - 12:15
3 May 2016 Research Published: BCG and New Preventive Tuberculosis Vaccines: Implications for Healthcare Workers. - 3 May 2016 - 09:00

April 2016

25 April 2016 Vacancy Study Coordinator - 25 Apr 2016 - 09:30
12 April 2016 Biomarker discovery offers hope for new TB vaccine development - 12 Apr 2016 - 18:45
11 April 2016 Announcement of large research grant to develop Oral Swab for TB Diagnosis - 11 Apr 2016 - 09:15

March 2016

23 March 2016 Determining a prognostic risk signature for clinical tuberculosis - 24 Mar 2016 - 20:00
24 March 2016 Community TB Newsletter published - 24 Mar 2016 - 13:15
24 March 2016 LANCET ARTICLE: A test to predict the risk of developing TB disease - 24 Mar 2016 - 09:15
23 March 2016 NEW VACANCY Quality Assurance Specialist - 23 Mar 2016 - 14:00
18 March 2016 Program to fight TB dropout rates delivers fruits - 17 Mar 2016 - 21:00
17 March 2016 Drama to highlight TB at the Worcester Easter Festival - 16 Mar 2016 - 23:45
15 March 2016 Vacancy Research Assistant - 15 Mar 2016 - 19:45
14 March 2016 SATVI team makes impact at SA Immunology Society Conference - 14 Mar 2016 - 23:00
2 March 2016 2015 SATVI Annual Report Released - 2 Mar 2016 - 12:00

February 2016

17 February 2016 Research Published: Evaluation of Xpert® MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine Trial. - 17 Feb 2016 - 21:30
14 February 2016 NEW RESEARCH: Real-Time Investigation of Tuberculosis Transmission: Developing the Respiratory Aerosol Sampling Chamber - 14 Feb 2016 - 15:15
12 February 2016 New Vacancies - 12 Feb 2016 - 17:15
2 February 2016 Research Published Individual-level factors associated with variation in mycobacterial-specific immune response: Gender and previous BCG vaccination status - 2 Feb 2016 - 10:00
2 February 2016 LATEST RESEARCH Individual-level factors associated with variation in mycobacterial-specific immune response: Gender and previous BCG vaccination status - 2 Feb 2016 - 09:15

January 2016

18 January 2016 Paper Published: First-in-human trial of a live-attenuated Mycobacterium tuberculosis vaccine - 18 Jan 2016 - 13:45
12 January 2016 Vacancy Research Officer NOW CLOSED - 12 Jan 2016 - 09:45

December 2015

18 December 2015 Radio interview: New Biomarker Test for TB - 18 Dec 2015 - 17:30
9 December 2015 Research Published - 9 Dec 2015 - 19:30
2 December 2015 Development of a biomarker test that predicts whether a person is at risk of developing TB. - 5 Dec 2015 - 15:15

November 2015

27 November 2015 Last patient vaccinated in GSK study - 26 Nov 2015 - 09:30
27 November 2015 SATVI announces the appointment of Chief Operations Officer - 25 Nov 2015 - 20:45
23 November 2015 NEW VACANCY: Research Officer (Clinical) - 23 Nov 2015 - 15:45
20 November 2015 Vacancy Medical Laboratory Technologists - 20 Nov 2015 - 12:15
17 November 2015 SATVI announces its participation in 46th Union World Conference on Lung Health in Cape Town from 2-6 December 2015 - 17 Nov 2015 - 17:15
10 November 2015 SATVI responds to the WHO Report on the Threat of TB - 10 Nov 2015 - 15:00

October 2015

29 October 2015 MTBVAC Study Commences - 29 Oct 2015 - 14:45
22 October 2015 Latest Research Published - 22 Oct 2015 - 21:15
9 October 2015 SATVI commences with Phase 2a TB vaccine candidate - 9 Oct 2015 - 13:00

Pages

Contact us

General Enquiries:

Tel +27 21 406 6791

Worcester Field Site Office

Tel+ 27 23 346 5400

Email: Information

Cape Town Offices:

Wernher and Beit South Building, Room S2.01, University of Cape Town , Anzio Road, OBSERVATORY, 7925

Tel: +27 21 406 6791

Fax:+27 21 406 6081

Email: Director

Worcester Site Office:

SATVI Project Office, University of Cape Town, Brewelskloof Hospital,  Haarlem Street, WORCESTER, 6850.

Tel: +27 23 346 5400

Fax: +27 23 346  5406

Email: Field Site Manager

Google maps:  Click here GPS: -33.620455, 19.458576

Map to Worcester Field Office